C

Compass Therapeutics Inc.
NASDAQ:CMPX

Watchlist Manager
Compass Therapeutics Inc.
NASDAQ:CMPX
Watchlist
Price: 2.87 USD -3.37% Market Closed
Market Cap: 396.9m USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+355%
Revenue
Forecast
+396%
Operating Income
Forecast
-3%
Net Income
Forecast
-4%

Wall Street
Price Targets

CMPX Price Targets Summary
Compass Therapeutics Inc.

Wall Street analysts forecast CMPX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CMPX is 13.06 USD with a low forecast of 6.06 USD and a high forecast of 33.6 USD.

CMPX Lowest Forecast
Wall Street Target
6.06 USD
111% Upside
CMPX Average Forecast
Wall Street Target
13.06 USD
355% Upside
CMPX Highest Forecast
Wall Street Target
33.6 USD
1 071% Upside
Lowest
Price Target
6.06 USD
111% Upside
Average
Price Target
13.06 USD
355% Upside
Highest
Price Target
33.6 USD
1 071% Upside
Compass Therapeutics Inc. Competitors:
Price Targets
NVAX
Novavax Inc
56% Upside
BRNS
Barinthus Biotherapeutics PLC
286% Upside
IKT
Inhibikase Therapeutics Inc
374% Upside
VICO
Vicore Pharma Holding AB
158% Upside
NVAX
Novavax Inc
56% Upside
BRNS
Barinthus Biotherapeutics PLC
286% Upside
IKT
Inhibikase Therapeutics Inc
374% Upside
VICO
Vicore Pharma Holding AB
158% Upside
PYC
PYC Therapeutics Ltd
167% Upside
LEGN
Legend Biotech Corp
103% Upside
CVAC
CureVac NV
10% Downside
COV
Covalon Technologies Ltd
45% Upside

Revenue
Forecast

Revenue Estimate
Compass Therapeutics Inc.

The compound annual growth rate of Compass Therapeutics Inc.'s revenue for the next 3 years is 396%.

N/A
Past Growth
396%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Compass Therapeutics Inc.

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Compass Therapeutics Inc.

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-19%
Average Miss
What are analyst estimates?

See Also

Summary
CMPX intrinsic value, competitors valuation, and company profile.
DCF Valuation
CMPX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CMPX stock valuation using valuation multiples.
Wall Street Estimates
CMPX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CMPX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CMPX's stock price target?
Price Target
13.06 USD

According to Wall Street analysts, the average 1-year price target for CMPX is 13.06 USD with a low forecast of 6.06 USD and a high forecast of 33.6 USD.

What is Compass Therapeutics Inc.'s Revenue forecast?
Projected CAGR
396%

The compound annual growth rate of Compass Therapeutics Inc.'s revenue for the next 3 years is 396%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 276,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.